A phase III study comparing sunitinib with sorafenib for advanced HCC

Authors
Category Primary study
Conference9th Annual Meeting of the Japanese Society of Medical Oncology; 2011 Jul 21-23; Yokohama, Japan. Annals of Oncology
Year 2011
This article has no abstract
Epistemonikos ID: 591d130f36486d8e648216fcd02621dc691539d4
First added on: Nov 24, 2021